A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. HCCs are genetically and phenotypically heterogeneous tumors characterized by very poor prognosis, mainly due to the lack, at present, of effective therapeutic options, as these tumors are rarely suitable for radiotherapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Stagni, Venturina, Santini, Simonetta, Barilà, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712690/
https://www.ncbi.nlm.nih.gov/pubmed/24213315
http://dx.doi.org/10.3390/cancers4020354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712690/
https://www.ncbi.nlm.nih.gov/pubmed/24213315
http://dx.doi.org/10.3390/cancers4020354

Ejemplares similares